Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1831 of 5804
-
Simple 5-Step nursing plan could slash deadly clot risk after hip surgery
Disease control OngoingVenous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), remains a critical and potentially life-threatening complication following total hip arthroplasty (THA). Despite standard prophylactic measures, the incidence of VTE can be significant…
Phase: NA • Sponsor: Murat Erten • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New balloon treatment for leg artery disease shows promise in Real-World study
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB by enrolling and tracking patients who underwent percutaneous transluminal angioplasty using GENOSS PCB in patients with femoropopliteal artery disease.
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can we predict lung transplant outcomes? new study seeks answers
Knowledge-focused OngoingPlain Language Summary of the PLUTO Study Prediction of Lung Transplant Outcomes (PLUTO) What is this study about? This study aims to improve how doctors predict the health of lung transplant recipients over time. Many people with severe lung disease need a transplant, but even …
Phase: NA • Sponsor: Hopital Foch • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study tracks how well nintedanib works over time for scleroderma lung disease
Disease control OngoingThis post-approval registry study is planned to generate data to address remaining questions on long-term effectiveness and to better characterize longer term beneficial effects of Nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) in te…
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
One-Shot knee injection could ease arthritis pain
Symptom relief Recruiting nowThis phase 2a trial is an international, multicenter, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of one single intra-articular (IA) injection of 4P004 or placebo in: * patients between 40 and 80 years of age, * with synovitis and gr…
Phase: PHASE2 • Sponsor: 4Moving Biotech • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New shoulder implant under real-world scrutiny: will it hold up?
Disease control Recruiting nowThis study is designed as a prospective, multicenter, observational post-market clinical follow-up (PMCF) study to evaluate the safety and effectiveness of the Tipmed™ Shoulder Prosthesis System at 12 months postoperatively. The study population includes adult patients who underg…
Sponsor: TIPMED Medical Device Manufacturing Ltd. Co. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can daily CBD reshape your stress response? a study puts it to the test.
Knowledge-focused Recruiting nowThe aim of this study is to determine the effects of regular cannabidiol (CBD) use on the psychobiological mechanisms of the stress response. This will be achieved by comparing acute stress responses of adults who either use or do not use CBD regularly. Correlates of CBD use, inc…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New Eye-Tracking tech could let AMD patients monitor vision loss from home
Diagnosis Recruiting nowAge-Macular Degeneration (AMD) is a common eye condition and a leading cause of vision loss among people age 50 and older. It causes damage to the macula, a small area near the centre of the retina needed for sharp, central vision. It is estimated that the prevalence of early and…
Phase: NA • Sponsor: Tan Tock Seng Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
New pill HRS-5041 tested in men with Tough-to-Treat prostate cancer
Disease control Recruiting nowTo evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of 5041-103 in Subjects with Metastatic Castration-resistant Prostate Cancer.
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
ER CT scan could keep heart patients out of hospital
Diagnosis Recruiting nowThe goal of this randomized clinical trial is to learn whether patients with symptomatic atrial fibrillation or atrial flutter (AF) who require heart imaging to rule out a blood clot before cardioversion would benefit from cardiac computed tomography angiography (CCT) in the emer…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New implant aims to seal anal fistulas without repeat surgery
Disease control Recruiting nowThis post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).
Sponsor: Signum Surgical USA Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New DNA test could uncover hidden eye infections
Diagnosis Recruiting nowThe aim of this study is to apply a diagnostic test called 'metagenomic sequencing' to identify the involvement of potential infections in patients with ocular inflammation, where this hasn't been detected by currently available standard testing. For many people with ocular infla…
Sponsor: Moorfields Eye Hospital NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
New eye drops aim to heal corneal damage and restore sensation
Disease control Recruiting nowThis is a Phase II, double-blind, placebo-controlled study to evaluate the safety and efficacy of STSP-0902 ophthalmic solution in patients with neurotrophic keratitis (NK). The study plans to enroll 48 patients with Mackie Stage 2 or 3 NK affecting one or both eyes. Eligible sub…
Phase: PHASE2 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Gout sufferers could ditch doctor visits with new Self-Monitoring app
Disease control Recruiting nowGout is caused by a reaction to urate crystals that results in attacks of severe joint pain. Medicines that lower urate levels can prevent gout flares, however it takes time for this benefit to be felt, and paradoxically starting treatment with large doses of urate lowering treat…
Phase: NA • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can botox help kids with cerebral palsy move better and feel happier?
Symptom relief Recruiting nowProject Identification and Researchers Title: "Changes in functionality and quality of life when applying the botulinum toxin type A infiltration protocol in children and adolescents with cerebral palsy of the spastic hemiparesis type GMFCS I and II, from the Teletón Institute Sa…
Phase: NA • Sponsor: Instituto Teletón Chile • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New telehealth program aims to ease daily struggles for advanced cancer patients
Symptom relief Recruiting nowThe goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-r…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Single-Incision armpit mastectomy could transform breast cancer surgery
Symptom relief Recruiting nowThis single-center prospective study will evaluate the feasibility and safety of endoscopic nipple-sparing mastectomy (E-NSM) performed through a single axillary incision in selected women with breast cancer undergoing direct-to-implant breast reconstruction. The study will asses…
Phase: NA • Sponsor: Fondazione del Piemonte per l'Oncologia • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Probiotics vs. Weight-Loss drug: which helps you shed pounds?
Disease control Recruiting nowThis study is a randomized controlled trial with 120 overweight or obese (body-mass index, BMI, ≥ 24 kg/m²) participants and 20 normal-weight participants. Twelve weeks of energy-restricted nutritional and lifestyle intervention with placebo, Lactobacillus paracasei LC-19 (LC-19)…
Phase: NA • Sponsor: Chinese Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Heart failure patients may get fit from home in new study
Disease control Recruiting nowThe goal of this observational study is to evaluate whether a home-based cardiac tele-rehabilitation program can improve functional capacity in adults (18 years and older) with chronic heart failure. The main questions it aims to answer are: Does tele-rehabilitation improve peak…
Sponsor: University of Salerno • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a fiber supplement improve PCOS heart risks?
Disease control Recruiting nowThis study will enroll women with PCOS to study the effects of first line therapy, oral contraceptive pills, and then either 12 weeks of resistant starch or 12 weeks of placebo to explore if resistant starch improves cardiometabolic parameters or impacts gut dysbiosis compared to…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC